Skip Nav Destination
Abstract PO-007: The Class I/IV HDAC Inhibitor Mocetinostat Augments Anti-Tumor Immune Responses in Melanoma Patients
Cancer Res (2020) 80 (23_Supplement): PO-007.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
- Elena-Georgiana Dobre
- Carolina Constantin
- Marieta Costache
- Monica Neagu
Journal of Personalized Medicine (2021) 11 (9): 901.
